# Investors and Partners

By [Evolko](https://dylit.info/user/evolko)

[Evolko Systems](https://dylit.info/presence/Evolko-Systems/69ccf3f195c1323244d6e180) > [Investors and Partners](https://dylit.info/channel/Investors-and-Partners/69cd126b95c1323244d6e55c)

The Chronic Care Market Thesis — Why This Moment Matters for Healthcare Investment We want to share the investment thesis behind Evolko directly and specifically — not the version optimised for a pitch deck, but a genuine articulation of why this market is where it is, why the timing is what it is, and why we believe Evolko is positioned meaningfully within it. Start with the population dynamics, because they are the unavoidable foundation of everything else. Roughly 129 million Americans live with at least one chronic condition. More than sixty million have two or more — the population eligible for Chronic Care Management reimbursement under Medicare. This number grows as the population ages, as obesity rates remain elevated, and as the downstream consequences of under-investment in preventive care continue to manifest. The physician workforce is not keeping pace: AAMC projections consistently show a shortage of between 54,000 and 139,000 physicians by 2033, concentrated heavily in primary care — precisely where chronic disease management demand is highest. The arithmetic of this mismatch does not resolve through supply-side interventions alone. It requires technology-enabled care delivery models that extend the effective capacity of the clinical workforce that already exists. The regulatory environment has moved decisively in support of this thesis. CMS introduced CCM reimbursement in 2015 and has expanded the programme progressively since — adding Principal Care Management codes in 2020, broadening Remote Patient Monitoring reimbursement, and introducing Advanced Primary Care Management codes that provide additional reimbursement for comprehensive care management. The direction of CMS policy is legible: the agency is structurally incentivising the shift from episodic, encounter-based care to continuous, relationship-based care management. Platforms built to deliver that model at scale are positioned on the right side of this regulatory trajectory. The financial opportunity at the practice level is real and currently underleveraged. The majority of eligible Medicare beneficiaries remain unenrolled in CCM programmes despite eligibility and clinical evidence supporting their effectiveness. The gap between reimbursement available and reimbursement captured is a function of operational complexity that most practices cannot absorb with existing infrastructure. This is precisely where Evolko operates. Our Revenue Cycle Management module consistently achieves a ninety-six percent clean claim rate. Our thirty-day onboarding commitment is the measured output of implementation accelerators developed through iterative practice deployments. We invite investors and strategic partners to explore this channel for the detailed market data, clinical outcomes metrics, and partnership models behind that position.